bupropion associated_with abstinence
Evidence from:
primary |
all sources
Evidence (3 sources)
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
(2013)
PMID:23249876
cited
Therapy randomization from baseline to EOT was to five different pharmacotherapies [NRT, BUP, PLA, VAR or combined NRT] ... and differ in prevalence of ... 6MO abstinence.
confidence: 0.90
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.
(2012)
PMID:22290489
cited
Data from a meta-analysis revealed that bupropion doubles abstinence rates for at least 6 months compared to placebo.
confidence: 0.97
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
individuals with the WT genotype and received bupropion had the highest abstinence rates.
confidence: 0.95